Aricept

Links shared publicly online about this topic

Generic Aricept (Donepezil) Clarification

alzheimersreadingroom.com — “The Alzheimers Reading Room has clear, concise, usable news, research, insight and advice for the entire Alzheimers disease community. The website focuses on the art of Alzheimers caregiving. Each day, 1,232 people are diagnosed with Alzheimers disease.View full resource at alzheimersreadingroom.com

  • View Related
  • Share

Most Recently Shared on January 6, 2011 at 3:06 pm By:

BobbyDelray Bob DeMarco Patient Advocate

BobbyDelray: Generic Aricept (Donepezil) Clarification http://bit.ly/icBIal

1 year ago...

ARICEPT (Donepezil) drug information from MPR

empr.com — “ARICEPT (Donepezil) drug information for Alzheimer's dementia from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on September 10, 2010 at 4:23 am By:

eMPR MPR Medical Publisher

MPR News: ARICEPT: 23mg tablet available. Adults: dosing updated. Adverse reactions: weight loss (esp. with 23mg/d... http://bit.ly/a3roNQ

1 year ago...

Aricept 23mg approved for Alzheimer's disease - MPR

empr.com — “The FDA has approved Eisai's Aricept (donepezil HCl tablets) in a 23mg dosage strenghth for the treatment of moderate-to-severe Alzheimer's disease.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on July 26, 2010 at 3:06 pm By:

eMPR MPR Medical Publisher

MPR News: Aricept 23mg approved for Alzheimer's disease: The FDA has approved Eisai's Aricept (donepezil HCl table... http://bit.ly/b1hMsu

2 years ago...

Aricept 23mg approved for Alzheimer's disease - ONA

oncologynurseadvisor.com — “The FDA has approved Eisai--™s Aricept (donepezil HCl tablets) in a 23mg dosage strength for the treatment of moderate-to-severe Alzheimer--™s disease.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on July 26, 2010 at 3:03 pm By:

FDA accepts to review Aricept NDA for Alzheimer's disease

news-medical.net — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept, a leading medication for the treatment of Alzheimer's disease.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 18, 2010 at 4:29 am By:

NewsMedical News-Medical.Net Health News

FDA accepts to review Aricept NDA for Alzheimer's disease: Teikoku Pharma USA, Inc., an international specialty ph... http://bit.ly/9cGJqS

1 year ago...

Alzheimer's and Aricept: Ban high Doses - latimes.com

latimes.com — “High doses of the Alzheimer's drug Aricept should be banned because it is not effective and has severe side effects, Public Citizen saysView full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on May 18, 2011 at 10:39 pm By:

LATimeshealth LA Times Health News Health News

High doses of Alzheimer's drug Aricept should be banned, Public Citizen says http://lat.ms/l844Hq

9 months ago...

Alzheimer's and Aricept: Ban high Doses - latimes.com

latimes.com — “High doses of the Alzheimer's drug Aricept should be banned because it is not effective and has severe side effects, Public Citizen saysView full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on May 19, 2011 at 9:30 pm By:

hrana Hisham Rana, MD Physician and Doctor

News: High doses of Alzheimer's drug Aricept should be banned, Public Citizen says http://lat.ms/iUgulI - #health #pharma

9 months ago...

High Dosages Of Alzheimer's Drug Aricept Ban, Watchdog Pushes FDA

medicalnewstoday.com — “The FDA is under pressure to ban studied high dosages of Aricept, a drug used to treat moderate or severe cases of Alzheimer's disease (AD) because of its risk of serious adverse effects and its lView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 19, 2011 at 5:05 pm By:

josephweaver Joe Weaver, RN Nurse

High Dosages Of Alzheimer's Drug Aricept Ban, Watchdog Pushes FDA http://bit.ly/kYUQpT

9 months ago...

Eisai Cuts Aricept Price in 6 Asian markets - Jack's posterous

pharmagossip.posterous.com — “Eisai Cuts Aricept Price in 6 Asian markets - Jack's posterousView full resource at pharmagossip.posterous.com

  • View Related
  • Share

Most Recently Shared on April 15, 2010 at 4:03 am By:

Aricept Controversy—Science or Marketing? | Suite101.com

suite101.com — “A public interest group wants to stop Aricept's new 23 mg dose. It'sView full resource at suite101.com

  • View Related
  • Share

Most Recently Shared on July 24, 2011 at 7:49 pm By:

HealthPassion HealthPassion Health News

Aricept Controversy--Science or Marketing?: A public interest group wants to stop Aricept's new 23 mg dose.... http://bit.ly/qpbqBo

7 months ago...

FDA allows Actavis to market generic Aricept in US - Pharmaceutical Business Review

regulatoryaffairs.pharmaceutical-business-review.com — “The US Food and Drug Administration (FDA) has given marketing approval to Actavis' Donepezil Hydrochloride Tablets, a generic equivalent of Aricept, iView full resource at regulatoryaffairs.pharmaceutical-business-review.com

  • View Related
  • Share

Most Recently Shared on June 3, 2011 at 12:38 am By:

SternNursing Lisa Ann Stern Nurse

FDA allows Actavis to market generic Aricept in US http://t.co/Pmb0Myk

8 months ago...

Eisai tells Pfizer to kiss Aricept goodbye - FiercePharma

fiercepharma.com — “Watch out: Eisai has challenged Pfizer to a tug-of-war over the Alzheimer's remedy Aricept. The Japanese drugmaker told Pfizer it has the right to nix their partnership on the drug, after Pfizer's... Read more...View full resource at fiercepharma.com

  • View Related
  • Share

Most Recently Shared on May 11, 2009 at 5:39 pm By:

High doses of Alzheimer's drug Aricept should be banned, Public Citizen says

physorg.com — “High doses of the Alzheimer's drug Aricept should be banned because they are no more effective than low doses and have a sharply increased risk of adverse effects, the advocacy group Public Citizen and a Johns Hopkins University geriatrician said Wednesday in a petition to the Food and Drug Administration.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on May 19, 2011 at 8:28 pm By:

physorg_health PhysOrg Health News Health News

High doses of Alzheimer's drug Aricept should be banned, Public Citizen says http://tw.physorg.com/225041256

9 months ago...

FDA accepts NDA for Aricept Patch for Alzheimer's disease (AD) - ONA

oncologynurseadvisor.com — “Eisai announced that the FDA has accepted for filing the New Drug Application (NDA) submitted for Aricept Patch (donepezil transdermal system) for the treatment of mild, moderate and severe stages of Alzheimer's disease (AD).View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on September 17, 2010 at 2:45 pm By:

FDA approves Aricept 23 mg tablet for Alzheimer's disease

news-medical.net — “Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept 23 mg tablet for the treatment of moderate-to-severe Alzheimer's disease (AD). Aricept 23 mg tablet offers another dosing option for patients with moderate-to-severe AD, for whom few treatments are availableView full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 26, 2010 at 6:48 am By:

Oncology_News News-Medical.Net Health News and Oncology

Oncology News: FDA approves Aricept 23 mg tablet for Alzheimer's disease: Eisai Inc. and Pfizer Inc announced toda... http://bit.ly/bUsCXG

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390